Caffeine / השמנת יתר חולנית

Composition comprising caffeine chromium and fructose for weight control and use thereof

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel composition useful for weight control. The invention further relates and to the use of the novel composition for the prevention or treatment of weight gain in a mammalian organism in need of such

Deuterated caffeine and uses thereof

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND Caffeine is a central nervous system (CNS) stimulant belonging to the methylxanthine chemical class. It is the world's most widely consumed psychoactive drug. Caffeine affects several biological processes. The most prominent is reversibly blocking the action of adenosine on the adenosine

Weight loss formulation

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a weight loss formulation, and more particularly, to a formulation comprising a known combination of herbal extracts to which is added further ingredients to enhance weight loss. 2. Description of Related Art A

Methods and compositions for producing weight loss

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

FIELD OF THE INVENTION This invention relates to methods and compositions for producing weight loss in mammals. One of the greatest problems confronting modem society in economically successful countries today is obesity. Unfortunately, obesity brings with it the conditions that are ripe for the

N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp derivatives

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted TRP derivatives

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

Amino acid analogs as CCK antagonists

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting as agonists at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh, and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes, and Pittaway, Neuropharmacology 26:289-300, 1987), and as

N-substituted cycloalkyl and polycycloalkyl polyhydro-.beta.-carboline-phenylalanine- and phenethylamine derivatives

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted Trp-Phe- and phenethylamine derivatives

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted Trp-Phe- and phenethylamine derivatives

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

Amico acid derivatives cyclized at the C-terminal

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE lNVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

Amino acid derivatives cyclized at the C-terminal

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

Amino acid derivatives cyclized at the C-terminal

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

Pro-drugs for CCK antagonists

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

caffeine/השמנת יתר חולנית

Composition comprising caffeine chromium and fructose for weight control and use thereof

Deuterated caffeine and uses thereof

Weight loss formulation

Methods and compositions for producing weight loss

N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp derivatives

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted TRP derivatives

Amino acid analogs as CCK antagonists

N-substituted cycloalkyl and polycycloalkyl polyhydro-.beta.-carboline-phenylalanine- and phenethylamine derivatives

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted Trp-Phe- and phenethylamine derivatives

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted Trp-Phe- and phenethylamine derivatives

N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives

Amico acid derivatives cyclized at the C-terminal

Amino acid derivatives cyclized at the C-terminal

Amino acid derivatives cyclized at the C-terminal

Pro-drugs for CCK antagonists

המאגר השלם ביותר של צמחי מרפא המגובה על ידי המדע